Hint mode is switched on Switch off

Beijing Hotgen Biotech, ordinary share
688068, CNE100003P82

Add a stock to WL
Choose all Reset all
Beijing Hotgen Biotech, сountry — China
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Dividends

Issuer

Profile
Beijing Hotgen Biotech Co Ltd researches, develops, and distributes in vitro diagnostic reagents and instruments. The Company also produces point of care testing and biodefense products. Beijing Hotgen Biotech serves hepatocellular carcinoma, cardio cerebral vascular disease, ...
Beijing Hotgen Biotech Co Ltd researches, develops, and distributes in vitro diagnostic reagents and instruments. The Company also produces point of care testing and biodefense products. Beijing Hotgen Biotech serves hepatocellular carcinoma, cardio cerebral vascular disease, inflammatory infection, and other clinical medical fields.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Beijing Hotgen Biotech Co Ltd
  • Industry
    Medical Devices

Related Stock indices

Indicators

News

15/11/2024 Hotgen Biotech to Buy Back Shares of Up to 100 Million Yuan
All organization news

Holders

Industry Leaders

Registration is required to get access.